Counterpoint Mutual Funds’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,931
Closed -$123K 446
2023
Q2
$123K Buy
6,931
+153
+2% +$2.6K 0.11% 156
2023
Q1
$121K Buy
+6,778
New +$127K 0.11% 46
2021
Q4
Sell
-726
Closed -$20K 242
2021
Q3
$20K Buy
+726
New +$19.4K 0.02% 118

Other funds holding TBI

Counterpoint Mutual Funds's TBI Position: Q3 2023 in Review

Counterpoint Mutual Funds sold out of Trueblue (TBI) in Q3 2023, closing a stake of 6,931 shares — an estimated $123K sold.

Counterpoint Mutual Funds first reported a position in TBI in Q3 2021 and held it in 3 quarters. The position peaked at $123K in Q2 2023. 144 funds tracked by Wall St. Rank hold TBI as of Q3 2023.

  • Counterpoint Mutual Funds reported no remaining Trueblue position as of Q3 2023 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 6,931 Trueblue shares in Q3 2023, an estimated $123K.
  • Counterpoint Mutual Funds first reported a position in Trueblue in Q3 2021 and held it in 3 quarters.
  • Counterpoint Mutual Funds's Trueblue position peaked at $123K in Q2 2023.
  • 144 funds tracked by Wall St. Rank held Trueblue as of Q3 2023.

Based on Counterpoint Mutual Funds's 13F filing for Q3 2023, filed 18 Oct 2023.